TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bronstein, Gewirtz & Grossman Llc
TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

A class action lawsuit has been filed against Telix Pharmaceuticals for allegedly making false statements about prostate cancer therapeutic candidates and supply chain quality during the period of February 21-August 28, 2025.

Insights
MAT   positive

Highlighted as a potential partner for Netflix's content expansion and merchandise opportunities


TLX   negative

The lawsuit alleges multiple material misrepresentations about the company's progress in prostate cancer therapeutics and supply chain quality, suggesting potential fraudulent or misleading corporate communications